Natco Pharma launches Hepatitis C drug in India

Natco Pharma launched fixed dose combination of Sofosbuvir-Daclatasvir tablets for the treatment of Hepatitis C under the brand name Hepcinat Plus.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news